Wednesday, March 28, 2012

Falana v. Kent State Univ.: determining the inventorship of chemical compounds


Source: http://www.venable.com/falana-v-kent-state-univ-determining-the-inventorship-of-chemical-compounds-03-20-2012/
The U.S. Court of Appeals for the Federal Circuit recently considered what activities rise to a contribution to conception that qualify one to be a joint inventor of a chemical compound in its opinion Falana v. Kent State Univ., No. 2011-1198 (Fed. Cir. Jan. 23, 2012).  The general law of inventorship is as follows.  The inventors listed on a patent include all individuals who made an inventive contribution to at least one claim.  That is, inventorship is determined on a claim-by-claim basis.  A person who conceived the complete subject matter of any claim, including all claimed features, has made an inventive contribution.  The mental act of conception is essential to inventorship.  A person may devote long hours to a project, and his or her efforts may be important to its commercial success, but if these efforts do not include the conception of claimed subject matter, the person is not an inventor.  For example, reducing to practice or carrying out the idea of another does not qualify one to be an inventor.  A person who provides general technical information without contributing to conception is not an inventor.  The collaboration of multiple individuals can complicate the determination of inventorship.  There must be at least one-way communication of information relevant to conception between two people for them to be considered joint inventors - individuals who independently conceive an idea cannot be joint inventors.
  
The facts in Falana are important to understanding the Federal Circuit's holding.  As a post-doctoral researcher at Kent State, plaintiff Dr. Olusegun Falana developed a synthesis protocol for making a novel class of naphthyl-substituted TADDOL (tetraaryl-1,3-dioxolan-4,5-dimethanol) compounds of use in LCDs (liquid crystal displays).  Among the compounds synthesized by Falana was Compound 7, which exhibited temperature independence over a range of -20 to +30 °C of the important high helical twisting power property.  This range of temperature independence represented significant progress, but was not sufficiently broad to meet the project goals.  Falana subsequently resigned from the research group.  Another member of the group, Dr. Alexander Seed, then used Falana’s synthesis protocol to synthesize a Compound 9 that exhibited temperature independence over a range -20 to +70 °C, meeting the goals of the project.  An application was filed, later issuing as U.S. Patent Number 6,830,789 (the "'789 Patent"), which listed Seed and others, but not Falana, as inventors.  The application included a generic claim 1 to a naphthyl-substituted TADDOL.  A "generic claim" to a chemical compound encompasses multiple individual compounds, for example, by allowing for the moiety substituted at a position on a molecule to be selected from a list of differing chemical groups.  Generic claim 1 did not expressly include a requirement for a temperature independence range of high helical twisting power.  Falana then filed the present case in the U.S. District Court of the Northern District of Ohio to be added as an inventor to the '789 Patent.  The District Court found for Falana, ruling that he contributed to the conception of the claimed invention and was to be added as an inventor.  The defendants, Kent State and Seed, then appealed to the Federal Circuit.
In their appeal, the defendants argued that the claims should have been construed to be limited to a compound "having a substantially temperature independent high helical twisting power," even though this limitation was not expressly recited in the claims, because the specification so described the inventive compounds, and, without such a limitation, the claimed compounds would be commercially worthless.  The Federal Circuit disagreed, finding no suggestion in the intrinsic record that the applicant intended to so limit the claims.  Therefore, the plain language of the claims governed.  The Federal Circuit affirmed the construction of the District Court, in which the claims were not limited to a compound "having a substantially temperature independent high helical twisting power."
The defendants further argued that even if Falana had contributed to the synthesis protocol, he was not a joint inventor, because the claims were all directed to compounds and not methods, invoking the decision in Bd. of Trs. of Fla. State v. Am. Biosci., 333 F.3d 1330, 67 USPQ2d 1252 (Fed. Cir. 2003).  The Federal Circuit distinguished Am. Biosci. on the facts, because the method of the putative co-inventor in that case was not used to make any of the compounds claimed in the patent at issue.  By contrast, in the present case, the method used to make the genus of compounds claimed in the '789 Patent was Falana's synthetic protocol.  The Federal Circuit agreed with the conclusion of the District Court that Falana's contribution to developing the synthetic protocol was greater than the exercise of ordinary skill in the art.
In Falana, the Federal Circuit held that an individual has contributed to the conception of a genus of chemical compounds and is an inventor of the genus when he or she (i) envisioned the structure of a novel genus and (ii) contributed the method, not already within the scope of public knowledge, of making that genus.  On the basis of this conception test, the Federal Circuit affirmed that Falana was an inventor of the '789 Patent.
From a practical perspective, Falana highlights the need to address inventorship and the distinct, but related, issue of ownership throughout the entire innovation cycle.  At the beginning of employment, individuals should sign an employee agreement that conveys intellectual property developed within the scope of employment to the employer.  When two or more companies collaborate on a project, an advance agreement should set forth the allocation of ownership of intellectual property developed.  Researchers should be educated about the standards of inventorship and the implications of acknowledging the putative contributions of third parties.  They should be encouraged to consult with patent counsel throughout the course of a project.  Such communication can help in avoiding missteps and tempering individual expectations.  The undesirable situation of having to resolve a dispute or even compete with a disgruntled individual who considers him or herself an incorrectly excluded inventor can be avoided through the early implementation of procedures to assess inventorship before patentable subject matter is perceived as being of substantial value. 

Thursday, March 24, 2011

Patent Reform Bill Passes Senate Judiciary Committee

On Feb. 3, 2011, the Senate Judiciary Committee voted on S. 23, the patent law reform bill. The was 15 in favor with 2 Senators voting present. This legislation has been pushed for several years mostly by Senator Leahy of Vermont. Several compromises since the original reform efforts failed have resulted in the bill in its current form. It is unclear what may happen in the House.

One of the popular provisions in an end to USPTO fee diversions. This means that fees the USPTO charges will not be diverted for general revenue uses. The USPTO will get to keep everything it collects and, hopefully, use the money to improve it's performance in prosecuting patents. That essentially means reducing the backlog of pending patents.

One of its most controversial provisions is a "first to file" rule, which would grant patent rights to whoever gets to the Patent Office first, eliminating the "first to invent" system that has been in place in the US since the patent system was established. This could cause a major change for small entities. Also controversial is the third party reexamination provision which makes it easier for third parties to challenge the validity of issued patents. These two provisions were pushed heavily by large corporations, especially those in the computer hardware, software, and IT industry. This provision and some others in the legislation are also put forth in the name of international harmonization since most of the world is first-to-file.

The Association of University Technology Managers is supportive. They believe that reform is inevitable and that this version is much better than past versions. Other groups are coming out in oppositions. Other than doing what is needed to fix the backlog, a strong argument can be made that we have historically the strongest innovation economy in the world and if it isn't broken, don't try to fix it.

We will write more about the debate as the legislation moves forward.

Friday, February 25, 2011

The USPTO's proposed program to allow expedited patent applications for an extra $4,000

The backlog of patent applications is still a big problem at the USPTO. To partially address this, the USPTO is proposing an expedited application option for an additional $4,000. In my opinion, before they do anything else, they should stop diverting fees currently charged to applicants to other federal programs and use those very substantial resources to address the backlog. This fee diversion has been happening for years now. Fees charged by the USPTO have always been intended to support the USPTO. Those fees should go towards improvements in quality and efficiency such as better staff training, more resources, and additional patent examiners.

Regarding this new proposal, what about start up companies, individuals, or not-for-profit research institutions (like universities) that can't afford to pay for expediting? Where does that leave them, delayed even further because the expedited applications are the priority over standard applications? It seems like this sets up a system of haves vs have-nots. The government should address the delays and fix the system for all applicants.

Monday, June 21, 2010

CNN.com's financial website has a story today about the pending patent reform legislation. It's an interesting read although the story, for the most part, is written from the perspective of some large businesses and their position on the issues. There is no doubt that there is a huge backlog of pending patents. Additionally, many patent professionals feel that overworked patent examiners do not have enough time to assure that valid, quality patents are being issued.

There are essentially two opposing camps in the patent reform political arena. One represents large companies, typically software/IT/hardware companies like Microsoft, IBM, Sun, Motorolla, Intel, etc. that support a first to file system, third party opposition to pending patents or post grant review, and a substantial reduction of potential infringement awards. Their arguments include a belief that jury awards from (weak) patents being asserted by patent "trolls" have been excessive and unfair.

On the other side, the pharmaceutical and biotech industry, which relies heavily on patents to protect their products, opposes pending reforms that would weaken (in their opinion) patent enforcement, especially third party oppositions and limits on damages. Independent inventor groups and small businesses share the position of the pharma industry and also oppose a first to file system. Universities are generally aligned with these groups due to a similarity of interests. The Association of University Technology Managers and other academia-based orgainizations have taken positions on the legislation.

This is one of those pieces of legislation that doesn't get a lot of press but could have a tremendous effect on the patent system and the innovation that comes from it - entrepreneurial efforts, new products, strong start up companies, and the jobs that are based upon all of this.

If you read the CNN article please note a substantial error. The author states that "inventors can sue for infringements on their intellectual property even if they never filed to patent it." This statement is simply factually incorrect and I am a little surprised that it remains in the story uncorrected. While pending patents provide a few limited benefits, you need an issued patent in-hand to have any enforceability under federal law.

Comments are welcome.

http://money.cnn.com/2010/06/21/technology/patent_reform/index.htm

Wednesday, January 20, 2010

Article on delays in the US Patent system

John Schmid and Ben Poston of the Milwaukee Journal Sentinel have written an excellent series of articles on issues and problems with the US Patent and Trademark Office. You can find the articles at the link below.

Problems with patent delays at the USPTO are getting to be a big deal . It's an especially substantial issue for technology-based start ups. If start ups can't get issued patents in a timely manner investors don't invest and growth doesn't occur. If growth doesn't occur those start ups don't employ additional people. On the technology licensing side of this, at SIUC we have at least a couple of inventions that probably would have already been licensed if the patents had been issued within a reasonable time period (and more likely to have been commercialized to the benefit of many including the general public). While it's not uncommon in many industries to license pending patents, in some industries that is very difficult to do and the norm is to have an issued patent in hand before a licensor can get a deal done.

An agency like the USPTO doesn't sound that interesting to the average American, I'm sure. However, it's a crucial cog in the engine of innovation that drives our economy.

http://www.jsonline.com/business/53319162.html